+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Bone Marrow Transplantation Market by Type, Treatment Type, End-User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 186 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 6011047
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Bone Marrow Transplantation Market grew from USD 16.27 billion in 2023 to USD 17.62 billion in 2024. It is expected to continue growing at a CAGR of 8.74%, reaching USD 29.26 billion by 2030.

Bone marrow transplantation (BMT) is a medical procedure to replace damaged or destroyed bone marrow with healthy marrow stem cells. This treatment is essential in therapies for leukemia, lymphoma, and severe aplastic anemia, among other blood-related diseases. There are two primary types: autologous, using the patient's cells, and allogeneic, using donor cells, each with distinct applications and outcomes. The end-use scope primarily encompasses hospitals and specialized treatment centers where highly skilled medical professionals can execute these intricate procedures. Market growth in BMT is driven by rising incidences of hematologic diseases and advancements in medical technology, enhancing procedural success rates and reducing recovery times. Opportunities arise in the development of personalized medicine and gene therapy, which have revolutionized tailored treatments leading to increased survival rates. Key platforms for harnessing opportunities include investing in R&D that focuses on gene editing technologies such as CRISPR or exploring less invasive procedures. Limitations to market growth include high costs associated with transplantation procedures, limited availability of suitable donors, and potential post-transplant complications such as graft-versus-host disease. Regulatory challenges and ethical concerns also pose significant barriers. Innovation should focus on expanding the donor pool using stored cord blood or engineered stem cells and improving transplant success rates with advanced immunity drugs. Businesses can benefit from insights into automated processing technologies and improved cryopreservation of cells, reducing logistical challenges and costs. The BMT market is inherently dynamic, marked by constant advancements in medical research and technology. Therefore, staying at the forefront requires continuous adaptation and integration of new scientific developments into practice, while addressing cost-related challenges to make treatments accessible to a broader patient base.

Understanding Market Dynamics in the Bone Marrow Transplantation Market

The Bone Marrow Transplantation Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Prevalence of blood cancer and improving accessibility to bone marrow transplantation
    • Increased commercialization of cell therapy and tissue engineering products
    • Government initiatives to improve awareness of the therapy
  • Market Restraints
    • High cost of the treatment and lack of reimbursement
  • Market Opportunities
    • Technological advancements in bone marrow transplantation therapy
    • Ongoing research & development activities of BMT
  • Market Challenges
    • Concerns related to GVHD, infections and relapse

Exploring Porter’s Five Forces for the Bone Marrow Transplantation Market

Porter’s Five Forces framework further strengthens the insights of the Bone Marrow Transplantation Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Bone Marrow Transplantation Market

External macro-environmental factors deeply influence the performance of the Bone Marrow Transplantation Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Bone Marrow Transplantation Market

The Bone Marrow Transplantation Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Bone Marrow Transplantation Market

The Bone Marrow Transplantation Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Bone Marrow Transplantation Market

The Bone Marrow Transplantation Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Bone Marrow Transplantation Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, American Type Culture Collection, Bayer AG, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Bristol Myers Squibb, Eli Lilly and Company, FUJIFILM Cellular Dynamics, Inc., Gamida Cell, Hemacare Corporation, Lifeline Cell Technology, Lonza Group AG, Magenta Therapeutics, Inc., Merck KgaA, Mesoblast Ltd., Novartis AG, PromoCell GmbH, Qiagen N.V., ReeLabs Pvt. Ltd., Sanofi-Aventis LLC, ScienCell Research Laboratories, Inc., and STEMCELL Technologies Inc..

Market Segmentation & Coverage

This research report categorizes the Bone Marrow Transplantation Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Type
    • Allogeneic Transplant
    • Autologous Transplant
  • Treatment Type
    • Aplastic Anemia
    • Leukemia
    • Lymphoma
    • Myelodysplastic Syndrome
    • Myeloma
    • Myeloproliferative Disorders
    • Sickle cell Anemia
    • Solid Tumors
    • Thalassemia
  • End-User
    • Ambulatory Surgical Centers
    • Hospitals
    • Multi-Specialty Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Prevalence of blood cancer and improving accessibility to bone marrow transplantation
5.1.1.2. Increased commercialization of cell therapy and tissue engineering products
5.1.1.3. Government initiatives to improve awareness of the therapy
5.1.2. Restraints
5.1.2.1. High cost of the treatment and lack of reimbursement
5.1.3. Opportunities
5.1.3.1. Technological advancements in bone marrow transplantation therapy
5.1.3.2. Ongoing research & development activities of BMT
5.1.4. Challenges
5.1.4.1. Concerns related to GVHD, infections and relapse
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Bone Marrow Transplantation Market, by Type
6.1. Introduction
6.2. Allogeneic Transplant
6.3. Autologous Transplant
7. Bone Marrow Transplantation Market, by Treatment Type
7.1. Introduction
7.2. Aplastic Anemia
7.3. Leukemia
7.4. Lymphoma
7.5. Myelodysplastic Syndrome
7.6. Myeloma
7.7. Myeloproliferative Disorders
7.8. Sickle cell Anemia
7.9. Solid Tumors
7.10. Thalassemia
8. Bone Marrow Transplantation Market, by End-User
8.1. Introduction
8.2. Ambulatory Surgical Centers
8.3. Hospitals
8.4. Multi-Specialty Clinics
9. Americas Bone Marrow Transplantation Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Bone Marrow Transplantation Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Bone Marrow Transplantation Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.4. Strategy Analysis & Recommendation
LIST OF FIGURES
FIGURE 1. BONE MARROW TRANSPLANTATION MARKET RESEARCH PROCESS
FIGURE 2. BONE MARROW TRANSPLANTATION MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2030 (%)
FIGURE 9. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 11. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS BONE MARROW TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 13. AMERICAS BONE MARROW TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. UNITED STATES BONE MARROW TRANSPLANTATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 15. UNITED STATES BONE MARROW TRANSPLANTATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. ASIA-PACIFIC BONE MARROW TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. ASIA-PACIFIC BONE MARROW TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BONE MARROW TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BONE MARROW TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. BONE MARROW TRANSPLANTATION MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 21. BONE MARROW TRANSPLANTATION MARKET, FPNV POSITIONING MATRIX, 2023
LIST OF TABLES
TABLE 1. BONE MARROW TRANSPLANTATION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. BONE MARROW TRANSPLANTATION MARKET DYNAMICS
TABLE 7. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY ALLOGENEIC TRANSPLANT, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY AUTOLOGOUS TRANSPLANT, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY APLASTIC ANEMIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY LEUKEMIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY LYMPHOMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY MYELODYSPLASTIC SYNDROME, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY MYELOMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY MYELOPROLIFERATIVE DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY SICKLE CELL ANEMIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY SOLID TUMORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY THALASSEMIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY MULTI-SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS BONE MARROW TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 28. ARGENTINA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 29. ARGENTINA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 30. ARGENTINA BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 31. BRAZIL BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 32. BRAZIL BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 33. BRAZIL BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 34. CANADA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 35. CANADA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 36. CANADA BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 37. MEXICO BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 38. MEXICO BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 39. MEXICO BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES BONE MARROW TRANSPLANTATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 44. ASIA-PACIFIC BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 45. ASIA-PACIFIC BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 46. ASIA-PACIFIC BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 47. ASIA-PACIFIC BONE MARROW TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 48. AUSTRALIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 49. AUSTRALIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 50. AUSTRALIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 51. CHINA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 52. CHINA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 53. CHINA BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 54. INDIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 55. INDIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 56. INDIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 57. INDONESIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 58. INDONESIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 59. INDONESIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 60. JAPAN BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 61. JAPAN BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 62. JAPAN BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 63. MALAYSIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 64. MALAYSIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 65. MALAYSIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 66. PHILIPPINES BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 67. PHILIPPINES BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 68. PHILIPPINES BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 69. SINGAPORE BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 70. SINGAPORE BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 71. SINGAPORE BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 72. SOUTH KOREA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 73. SOUTH KOREA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 74. SOUTH KOREA BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 75. TAIWAN BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 76. TAIWAN BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 77. TAIWAN BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 78. THAILAND BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 79. THAILAND BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 80. THAILAND BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 81. VIETNAM BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 82. VIETNAM BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 83. VIETNAM BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 84. EUROPE, MIDDLE EAST & AFRICA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 86. EUROPE, MIDDLE EAST & AFRICA BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 87. EUROPE, MIDDLE EAST & AFRICA BONE MARROW TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 88. DENMARK BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 89. DENMARK BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 90. DENMARK BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 91. EGYPT BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 92. EGYPT BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 93. EGYPT BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 94. FINLAND BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 95. FINLAND BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 96. FINLAND BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 97. FRANCE BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 98. FRANCE BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 99. FRANCE BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 100. GERMANY BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 101. GERMANY BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 102. GERMANY BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 103. ISRAEL BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 104. ISRAEL BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 105. ISRAEL BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 106. ITALY BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 107. ITALY BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 108. ITALY BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 109. NETHERLANDS BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 110. NETHERLANDS BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 111. NETHERLANDS BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 112. NIGERIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 113. NIGERIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 114. NIGERIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 115. NORWAY BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 116. NORWAY BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 117. NORWAY BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 118. POLAND BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 119. POLAND BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 120. POLAND BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 121. QATAR BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 122. QATAR BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 123. QATAR BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 124. RUSSIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 125. RUSSIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 126. RUSSIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 127. SAUDI ARABIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 128. SAUDI ARABIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 129. SAUDI ARABIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 130. SOUTH AFRICA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 131. SOUTH AFRICA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 132. SOUTH AFRICA BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 133. SPAIN BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 134. SPAIN BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 135. SPAIN BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 136. SWEDEN BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 137. SWEDEN BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 138. SWEDEN BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 139. SWITZERLAND BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 140. SWITZERLAND BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 141. SWITZERLAND BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 142. TURKEY BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 143. TURKEY BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 144. TURKEY BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 145. UNITED ARAB EMIRATES BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 146. UNITED ARAB EMIRATES BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 147. UNITED ARAB EMIRATES BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 148. UNITED KINGDOM BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 149. UNITED KINGDOM BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 150. UNITED KINGDOM BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 151. BONE MARROW TRANSPLANTATION MARKET SHARE, BY KEY PLAYER, 2023
TABLE 152. BONE MARROW TRANSPLANTATION MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Bone Marrow Transplantation market, which are profiled in this report, include:
  • Abbott Laboratories
  • American Type Culture Collection
  • Bayer AG
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Bristol Myers Squibb
  • Eli Lilly and Company
  • FUJIFILM Cellular Dynamics, Inc.
  • Gamida Cell
  • Hemacare Corporation
  • Lifeline Cell Technology
  • Lonza Group AG
  • Magenta Therapeutics, Inc.
  • Merck KgaA
  • Mesoblast Ltd.
  • Novartis AG
  • PromoCell GmbH
  • Qiagen N.V.
  • ReeLabs Pvt. Ltd.
  • Sanofi-Aventis LLC
  • ScienCell Research Laboratories, Inc.
  • STEMCELL Technologies Inc.

Methodology

Loading
LOADING...

Table Information